Merkel cell carcinoma of the skin: deducing the pattern of spread from an international aggregated database of 949 patients

dc.contributor.authorTai, Patriciaen
dc.contributor.authorJoseph, Kurianen
dc.contributor.authorPrajapati, Vimal H.en
dc.contributor.authorJones Thachuthara, Aoifeen
dc.contributor.authorLian, Jidongen
dc.contributor.authorAssouline, Avien
dc.contributor.authorYu, Edwarden
dc.contributor.authorVeness, Michaelen
dc.date.accessioned2025-05-13T08:54:25Z
dc.date.available2025-05-13T08:54:25Z
dc.date.issued2025en
dc.description.abstract(1) Background: It is controversial if Merkel cell carcinomas (MCCs) spread to lymph nodes or distant metastases (LNM/DM) first. (2) Methods: A total of 303 patients from six institutions (March 1982–February 2015) were combined with individual patient data from a PubMed search, totaling 949 patients. The primary outcome was recurrence patterns. (3) Results: (a) More patients presented with lymph node metastases (LNMs) than DMs at diagnosis: 17.9% (166 among the 929 patients with known staging) vs. 1.9% (18/929); (b) 310/929 (33.4%) developed lifetime DM, of whom 220/310 also developed LNM. The majority (133 patients) of patients were documented to have developed LNM before DM. (c) A shorter median time of 1.5 months (range: 0–47.0) from initial diagnosis to LNM, versus 8 months (range: 0–107.8) to DM, was also found. Another observation was that 2.4% (23/949) of patients with primary tumors ≤1 cm developed lifetime DM, with the smallest being 0.2 cm. (4) Conclusions: Three observations support the idea that prior LNM gives rise to subsequent DM as the main pathway of dissemination in MCC. This implies that patients with nodal metastases should be considered for adjuvant systemic therapy studies as an enriched population. Participation in clinical trials is strongly encouraged.en
dc.description.statusPeer revieweden
dc.description.versionPublished Versionen
dc.format.mimetypeapplication/pdfen
dc.identifier.articleid211en
dc.identifier.citationTai, P., Joseph, K., Prajapati, V. H., Jones Thachuthara, A., Lian, J., Assouline, A., Yu, E. and Veness, M. (2025) 'Merkel cell carcinoma of the skin: deducing the pattern of spread from an international aggregated database of 949 patients', Current Oncology, 32(4), p.211. https://doi.org/10.3390/curroncol32040211en
dc.identifier.doi10.3390/curroncol32040211en
dc.identifier.issn17187729en
dc.identifier.issued4
dc.identifier.journaltitleCurrent Oncologyen
dc.identifier.urihttps://hdl.handle.net/10468/17452
dc.identifier.volume32
dc.language.isoenen
dc.publisherMultidisciplinary Digital Publishing Institute (MDPI)en
dc.rights© 2025, the Author(s). Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.en
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.subjectDatabaseen
dc.subjectLocal recurrenceen
dc.subjectMerkel-cell carcinomaen
dc.subjectPattern of spreaden
dc.subjectRadiotherapy doseen
dc.subjectSkinen
dc.titleMerkel cell carcinoma of the skin: deducing the pattern of spread from an international aggregated database of 949 patientsen
dc.typeArticle (peer reviewed)en
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
curroncol-32-00211.pdf
Size:
965.4 KB
Format:
Adobe Portable Document Format
Description:
Published Version